ClinicalTrials.gg
DrugBiological

Ganitumab clinical trials

Also written AMG 479.

studies test it
29
open now
2
in phase 3
2
first study started
2005

How each study uses ganitumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ganitumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ganitumab
14
Anti-IGF-1R Human Monoclonal Antibody AMG-479
2

Development codes

AMG 479
22

Studies by the year they started

29 studies that test it; most in 2009 (6)

Studies that test ganitumab, by start year
YearStudies
20051
20061
20072
20083
20096
20104
20112
20126
20141
20171
20191
20251

By phase

A phase 1/2 study counts in both.

Phase 1
15
Phase 2
21
Phase 3
2
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 13

NantCell, Inc. (9) · NantBioScience, Inc. (3) · National Cancer Institute (NCI) (2) · Amgen (2) · Dana-Farber Cancer Institute (2) · Translational Research in Oncology (2) · M.D. Anderson Cancer Center (2) · Jeffrey Clarke (1)

Often tested with

Tested in the same studies.

Conatumumab (4) · Panitumumab (2) · Rilotumumab (2) · Everolimus (2) · Doxorubicin (1) · Ifosfamide (1) · Irinotecan (1) · Pazopanib (1)

Studies

Open first, then newest update. How each study uses ganitumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 29

See all 29 studies that test ganitumab →

Codes

What other systems call ganitumab · ClinicalTrials.gg INT005541

  • MeSH (NLM) C545764ganitumabConfirmed NLM, Wikidata
  • UNII (FDA) CK1441RCZ8GANITUMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q5521322ganitumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C71531GanitumabOne source FDA
  • DrugBank DB12205One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.